|
Panacos Pharmaceuticals, Incorporation - Company Profile Snapshot
| Company Profile: |
Panacos Pharmaceuticals, Incorporation |
| Ticker: |
PANC |
| Exchanges: |
NAS OTC |
| 2007 Sales: |
180,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED STATES |
| Employees: |
41 |
Business Description
Panacos Pharmaceuticals, Incorporation. The Group's principal activity is the discovery, development and commercialization of small molecule oral drugs for the treatment of HIV and other major human viral diseases. PA-457, its lead product candidate, is an oral HIV drug currently in Phase 2 clinical trials. PA-457 is a drug called Maturation Inhibitors discovered by its scientists and their academic collaborators. It has anti-infective drug candidates in pipeline for major markets with significant, unmet medical needs. The Group is a development stage company.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
